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Abstract
Background: Dietary modification via caloric restriction is associated with multiple effects related to improved
metabolic and cardiovascular health. However, a mandated reduction in kilocalories is not well-tolerated by many
individuals, limiting the long-term application of such a plan. The Daniel Fast is a widely utilized fast based on the
Biblical book of Daniel. It involves a 21 day ad libitum food intake period, devoid of animal products and preservatives,
and inclusive of fruits, vegetables, whole grains, legumes, nuts, and seeds. The purpose of the present study was to
determine the efficacy of the Daniel Fast to improve markers of metabolic and cardiovascular disease risk.
Methods: 43 subjects (13 men; 30 women; 35 ± 1 yrs; range: 20-62 yrs) completed a 21 day period of modified food
intake in accordance with detailed guidelines provided by investigators. All subjects purchased and prepared their own
food. Following initial screening, subjects were given one week to prepare for the fast, after which time they reported
to the lab for their pre-intervention assessment (day 1). After the 21 day fast, subjects reported to the lab for their post-
intervention assessment (day 22). For both visits, subjects reported in a 12 hr fasted state, performing no strenuous
physical activity during the preceding 24-48 hrs. At each visit, mental and physical health (SF-12 form), resting heart rate
and blood pressure, and anthropometric variables were measured. Blood was collected for determination of complete
blood count, metabolic panel, lipid panel, insulin, HOMA-IR, and C-reactive protein (CRP). Subjects’ self-reported
compliance, mood, and satiety in relation to the fast were also recorded. Diet records were maintained by all subjects
during the 7 day period immediately prior to the fast (usual intake) and during the final 7 days of the fast.
Results: Subjects’ compliance to the fast was 98.7 ± 0.2% (mean ± SEM). Using a 10 point scale, subjects’ mood
and satiety were both 7.9 ± 0.2. The following variables were significantly (p < 0.05) lower following the fast as
compared to before the fast: white blood cell count (5.68 ± 0.24 vs. 4.99 ± 0.19 10
3·μL
-1), blood urea nitrogen
(13.07 ± 0.58 vs. 10.14 ± 0.59 mg·dL
-1), blood urea nitrogen/creatinine (14.74 ± 0.59 vs. 11.67 ± 0.68), protein (6.95
± 0.07 vs. 6.77 ± 0.06 g·dL
-1), total cholesterol (171.07 ± 4.57 vs. 138.69 ± 4.39 mg·dL
-1), LDL-C (98.38 ± 3.89 vs.
76.07 ± 3.53 mg·dL
-1), HDL-C (55.65 ± 2.50 vs. 47.58 ± 2.19 mg·dL
-1), SBP (114.65 ± 2.34 vs. 105.93 ± 2.12 mmHg),
and DBP (72.23 ± 1.59 vs. 67.00 ± 1.43 mmHg). Insulin (4.42 ± 0.52 vs. 3.37 ± 0.35 μU·mL
-1; p = 0.10), HOMA-IR
(0.97 ± 0.13 vs.0.72 ± 0.08; p = 0.10), and CRP (3.15 ± 0.91 vs. 1.60 ± 0.42 mg·L
-1; p = 0.13), were lowered to a
clinically meaningful, albeit statistically insignificant extent. No significant difference was noted for any
anthropometric variable (p > 0.05). As expected, multiple differences in dietary intake were noted (p < 0.05),
including a reduction in total kilocalorie intake (2185 ± 94 vs. 1722 ± 85).
Conclusion: A 21 day period of modified dietary intake in accordance with the Daniel Fast is 1) well-tolerated by
men and women and 2) improves several risk factors for metabolic and cardiovascular disease. Larger scale,
randomized studies, inclusive of a longer time period and possibly a slight modification in food choice in an
attempt to maintain HDL cholesterol, are needed to extend these findings.
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Caloric restriction has been reported in a number of
studies to improve overall health in both humans [1]
and animals [2]. Additionally, caloric restriction has
been shown to increase the lifespan of many different
species [3]. Although many hypotheses have been pro-
posed in an attempt to explain these findings, the two
that have garnered the greatest amount of credence in
the scientific community are the oxidative damage
attenuation hypothesis and the hormesis hypothesis.
The oxidative damage attenuation hypothesis proposes
that caloric restriction extends life by attenuating mole-
cular oxidative damage [4]. The hormesis hypothesis
poses that caloric restriction - through its function as a
low-intensity stressor - builds up an animal’s tolerance
to higher-intensity stressors that would otherwise threa-
ten its survival [5].
While the total amount of dietary energy appears
important in regards to metabolic and cardiovascular
health, the specific type of food consumed may be
equally important [6,7]. This has been demonstrated in
animal trials in which dietary modification (typically via
protein manipulation or methionine manipulation) has
been associated with improved health and longevity [8].
In human trials it has been noted that “natural” foods
such as fruits, vegetables, whole grains, nuts and seeds,
which contain little or no preservatives, little to no satu-
rated fats, with an abundance of fiber and micronutri-
ents, may provide health enhancing properties [9-11].
Such a diet is often lower in total kilocalories by default,
as these foods provide greater satiety than more energy-
dense foods [12]. It follows that a dietary approach
inclusive of these food choices may be considered ideal
for individuals seeking enhanced health through nutrient
intake.
Although many diet plans are currently available,
those used in research studies focused on caloric restric-
tion for improved health and longevity routinely involve
a reduction of dietary energy equal to approximately
20 - 40% of an individual’s usual intake [13]. Other plans
involve short periods of caloric restriction followed by
normal intake, done in a cyclic pattern [14]. Other plans
involve “alternate day” fasting, in which no food is con-
sumed for one day, followed by ad libitum intake on the
subsequent day, done in a cyclic pattern [15]. The one
commonality of these diet plans is that individuals can
maintain their usual food choices; they simply need to
eat less of those foods. This regimen assumes that the
quantity of food is more important than the quality.
An alternative approach that has received a great deal
of attention in recent years from the non-scientific com-
munity is the “Daniel Fast”. The concept of the Daniel
Fast comes from Daniel 1:8-14 (NIV), “But Daniel
resolved not to defile himself with the royal food and
wine, and he asked the chief official for permission not
to defile himself this way. Now God had caused the offi-
cial to show favor and sympathy to Daniel, but the offi-
cial told Daniel, ‘Ia ma f r a i do fm yl o r dt h ek i n g ,w h o
has assigned your food and drink. Why should he see
you looking worse than the other young men your age?
The king would then have my head because of you.’
Daniel then said to the guard whom the chief official
had appointed over Daniel, Hananiah, Mishael and
Azariah, ‘Please test your servants for ten days: Give us
nothing but vegetables to eata n dw a t e rt od r i n k .T h e n
compare our appearance with that of the young men
who eat the royal food, and treat your servants in accor-
dance with what you see.’ So he agreed to this and
tested them for ten days.” Other Biblical translations
replace the word “vegetables” with “pulse”,w h i c hi n d i -
cates “food grown from seed”.
An additional reference to this fast is found in Daniel
10:2-3 (NIV): “At that time I, Daniel, mourned for three
weeks. I ate no choice food; no meat or wine touched
my lips; and I used no lotions at all until the three
weeks were over.” Based on this latter passage, a Daniel
Fast is most commonly partaken for 21 days, although
fasts of 10 and 40 days have also been observed. A
Daniel Fast involves ad libitum intake of specific foods,
but the food choices are restricted to essentially fruits,
vegetables, whole grains, nuts, seeds, and oil. This plan
resembles a vegan diet, which has been reported to yield
health enhancing properties [16,17]. However, a Daniel
Fast is more stringent, in that aside from the exclusion
o fa l la n i m a lp r o d u c t s ,t h ere are no processed foods,
white flour products, preservatives, additives, sweeteners,
flavorings, caffeine, or alcohol allowed in this plan.
Despite this, as individuals traditionally follow this fast
for religious purposes in an attempt to become “closer
to God” during a time of extended prayer, anecdotal
reports indicate that maintenance of the fast can be
achieved by most.
The aim of the present study was to investigate the
metabolic and cardiovascular health effects of the Daniel
Fast in human subjects. To our knowledge, this was the
first scientific investigation of the Daniel Fast. As such,
this study simply involved a pre/post assessment and
did not include random assignment to two different
dietary plans. Moreover, we did not attempt to limit
recruitment only to those with known risk factors for
cardiovascular and metabolic disease, as we were curious
to see how all individuals responded to such a dietary
plan. In addition to our interest in the measured anthro-
pometric, hemodynamic, and biochemical outcome vari-
ables, our objective with this initial study was to
determine the feasibility of maintaining this dietary
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with and tolerated the fast.
Methods
Subjects and Screening
Forty-four subjects (13 men; 31 women) were initially
recruited to participate and were enrolled in this study.
The mean age of subjects was 35 ± 1 years, with a range
of 20-62 years. One female subject had a diagnosis of
well-controlled type II diabetes (and used oral hypogly-
cemic agents), and one male subject had a history of
coronary artery bypass graft surgery (and used both a
statin and Plavix®). Three subjects were hypertensive
upon enrollment (BP≥140/90 mmHg; 2 men and 1
woman) and seven had hypercholesterolemia (total cho-
lesterol > 200 mg·dL
-1; 1 man and 6 women). One man
used a beta blocker and one man used an anti-depres-
sant. Three women used anti-depressants, six used oral
contraceptives, two used estrogen replacement, two used
a sleep aid, one used a statin, and one used an angioten-
sin II receptor antagonist.
Six female subjects were vegetarian prior to starting
the fast. No restrictions were placed on subjects
regarding body mass necessary for enrollment. Hence,
the BMI of subjects ranged from 18.0 kg·m
-2 to
40.6 kg·m
-2, with 21 subjects classified as normal
weight (BMI < 25 kg·m
-2), 10 classified as overweight
(BMI 25-29.9 kg·m
-2), and 13 classified as obese (BMI
≥30 kg·m
-2). All subjects were nonsmokers. Of the
44 subjects, 34 were classified as exercise trained, per-
forming 1.8 ± 0.24 hours of anaerobic and 3.0 ± 0.23
hours of aerobic exercise per week for the past 5.4 ±
0.82 and 7.7 ± 1.0 years, respectively. Subjects were
classified as exercise trained if they regularly per-
formed a combined minimum of three hours per week
of anaerobic and aerobic exercise of moderate to high
intensity. Collectively, subjects were relatively healthy,
active men and women. Eligibility and classification
was determined by completion of health history, drug
and dietary supplement usage, and physical activity
questionnaires. Prior to participation, each subject was
informed of all procedures, potential risks, and benefits
associated with the study through both verbal and
written form in accordance with the approved proce-
dures of the University Institutional Review Board for
Human Subjects Research (H10-06). Subjects signed an
informed consent form prior to being admitted as a
subject.
During the initial visit to the laboratory, subjects com-
pleted all paperwork, were provided detailed instructions
for the fast, were given food logs for dietary recording
and reviewed food models in an attempt to improve
accuracy of recording (as described below), and were
provided a calendar outlining their full participation.
While numerous websites are available with information
and recipes related to the Daniel Fast, subjects were
provided a detailed outline of those foods that are
allowed, as well as commonly consumed foods that are
not allowed. A recipe guide was also provided. It is
important to note that subjects purchased and prepared
their own food. Subjects returned to the lab 1-2 weeks
later to have baseline assessments performed and to
begin the 21 day fast. The outcome variables described
below were measured before (baseline: day 1 of the fast)
and after the fast (day 22). All data collection was done
in the morning hours (5:00-11:00 am) in a 12 hour
fasted state.
SF-12 Questionnaire
Upon arrival to the lab, subjects were asked to complete
a questionnaire pertaining to their overall mental and
physical health status (SF-12v2; QualityMetric, Inc.).
The questionnaire was delivered using a computer based
program and scoring was performed using automated
software immediately following completion of the
questionnaire.
Heart Rate and Blood Pressure
Following completion of the above questionnaire, sub-
jects were asked to void. Women performed a urine preg-
nancy test to confirm that they were not pregnant, as
pregnant women were not allowed to participate in this
study due to potential fetal radiation exposure with the
dual energy x-ray absorptiometry (DEXA) scan. Subjects
were then seated in a chair with a blood pressure cuff
placed on their left arm. Subjects rested for 10 minutes,
after which time heart rate was measured via palpation
for 60 seconds using the radial artery (by two trained
technicians–one on each wrist). Blood pressure was then
measured via auscultation using a calibrated manometer
and a dual earpiece stethoscope that allowed for two
trained technicians to listen simultaneously. Duplicate
measures were obtained for both heart rate and blood
pressure (hence a total of four measures for each variable,
two from each technician) and the average of all mea-
sures was used in data analysis. If values deviated by
more than 5 bpm for heart rate or 5 mmHG for blood
pressure, an additional measure was taken.
Anthropometric Variables
Subjects’ height was measured using a stadiometer, and
body weight was measured using a calibrated medical
scale. Body mass index was calculated as weight (kg)
divided by height (m
2). Waist and hip circumference
measurements were obtained using a tension-regulated
tape measure, with subjects wearing “spandex-like”
shorts. Body composition was determined by DEXA
(Hologic QDR-4500W) using a 4-minute fan array.
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were determined. The assessment was performed by a
licensed technician.
Blood Collection and Biochemical Variables
Venous blood samples were taken from subjects’ fore-
arm via needle and Vacutainer™ b yat r a i n e dp h l e b o t o -
mist. Following collection, samples were processed
accordingly to obtain plasma/serum. All assays were
performed with 24 hours of sample collection. Complete
blood count was determined using an automated cell
counter (Coulter LH750). The comprehensive metabolic
panel was determined using automated procedures
(Roche/Hitachi Modular). The lipid panel was deter-
mined using enzymatic procedures (Roche/Hitachi
Modular). Insulin was determined using an immuno-
chemiluminescent assay procedure (Roche Modular
E170). C-reactive protein was determined using a high-
sensitivity, particle-enhanced turbidimetric immunoassay
(Roche Integra 800). The homeostasis model assessment
(HOMA-IR) was used as an index of insulin resistance
[18] and calculated as: [fasting glucose (mg·dL
-1) × fast-
ing insulin (μU·mL
-1)]/405.
Dietary Records and Physical Activity
All subjects were instructed to maintain their normal
diet until they began the fast and to record on data
forms all food and beverage consumed during the
seven days immediately prior to the start of the fast.
Subjects were also asked to record food and beverage
intake during the final seven days of the fast. A techni-
cian reviewed in detail the nutritional records with
each subject upon receipt. Records were analyzed by
using Food Processor SQL, version 9.9 (ESHA
Research, Salem, OR). Regarding physical activity, sub-
jects were instructed to maintain their normal habits
during the entire study period. Subjects were
instructed to refrain from alcohol consumption during
the fast and to avoid strenuous exercise during the 24-
48 hours immediately preceding the two assessment
days.
Compliance, Mood, and Satiety
On a scale of 0-100 (0 = complete non-compliance,
100 = complete compliance), subjects rated their overall
compliance to the fast, with regards to food choices.
Using a 10 point visual analog scale (0 = worst possible
mood/extreme hunger, 10 = best possible mood/com-
plete satiety), subjects rated their overall mood and feel-
ing of satiety while on the fast.
Statistical Analysis
All data were analyzed using a t-test. Analyses were per-
formed using JMP statistical software (version 4.0.3, SAS
Institute, Cary, NC). Statistical significance was set at
P ≤ 0.05. The data are presented as mean ± SEM.
Results
Compliance, Mood, and Satiety
Forty-four subjects were initially enrolled in the study,
and all 44 subjects completed the 21 day fast, as well as
pre and post assessments. However, one subject
reported a compliance rate of only 60% to the fast and
was therefore excluded from data analysis. Of the
remaining 43 subjects, compliance to the fast was 98.7 ±
0.2%. Subjects’ overall mood during the fast was indi-
cated at 7.9 ± 0.2, while satiety during the fast was indi-
cated at 7.9 ± 0.2.
Through completion of a post fast questionnaire, sub-
jects reported that the main enervation of their mental
health was the omission of caffeine. However, aside
from caffeine, there was no one particular food item
that impaired subjects’ mental outlook or limited sub-
jects’ interest in complying with the fast guidelines. Sub-
jects noted that they enjoyed the ad libitum nature of
the plan, as well as the wide variety of food choices. In
fact, most subjects reported that they would continue
implementing many components of the plan into their
previous diets. Finally, subjects reported that selecting
food items that complied with the fast guidelines, in
addition to planning and preparing meals, were the
most challenging components of the fast. That being
said, subjects commented repeatedly that the forced
review of food labels significantly increased their knowl-
edge and awareness of the kilocalorie content and
macro- and micro-nutrient composition of foods, as
well as the inclusion of additives and preservatives.
Hence, such a program may very well serve as an educa-
tion in food choices, rather than merely a method to
improve metabolic and cardiovascular health.
In relation to the bloodborne variables, we were able
to obtain blood samples on 42 of the 43 subjects. Of the
42 subjects for which blood samples were obtained, pre
a n dp o s ti n s u l i nv a l u e sw e r en o ti n c l u d e df o rt w os u b -
jects and CRP values were not included for one subject,
due to problems in sample analysis.
Mental and Physical Health, Hemodynamic, and
Anthropometric Data
No differences were noted from pre to post fast for
mental (p = 0.45) or physical (p = 0.93) health. No dif-
ferences were noted from pre to post fast for body
weight (p = 0.52), BMI (p = 0.43), waist circumference
(p = 0.65), hip circumference (p = 0.62), waist:hip
(p = 0.86), percent total body fat (p = 0.86), % trunk
body fat (p = 0.77), fat mass (p = 0.64), or fat free mass
(p = 0.60). No difference was noted from pre to post
fast for resting heart rate (p = 0.13). However, systolic
Bloomer et al. Lipids in Health and Disease 2010, 9:94
http://www.lipidworld.com/content/9/1/94
Page 4 of 9(p = 0.007) and diastolic (p = 0.03) blood pressure were
both lower post fast compared to pre fast. Data for all
variables are presented in Table 1.
Biochemical Data
With the exception of white blood cells, which were
l o w e rp o s tf a s tc o m p a r e dt op r ef a s t( p=0 . 0 3 ) ,n od i f -
ferences were noted for complete blood count variables
(p > 0.05; Table 2). With the exception of blood urea
nitrogen (p = 0.003), blood urea nitrogen:creatinine (p =
0.005), and protein (p = 0.05), which were all lower post
fast compared to pre fast, no differences were noted for
metabolic panel variables (p > 0.05; Table 3). Total cho-
lesterol (p < 0.0001), LDL-C (p = 0.0004), and HDL-C
(p = 0.02) were all lower post fast compared to pre fast.
No difference was noted for VLDL (p = 0.12), Total:
HDL (p = 0.47), or triglyceride (p = 0.12). Data are pre-
sented in Table 4. Insulin (pre: 4.42 ± 0.52 vs. post: 3.37
±0 . 3 5μU·mL
-1; p = 0.10), HOMA-IR (pre: 0.97 ± 0.13
vs. post: 0.72 ± 0.08; p = 0.10), and CRP (pre: 3.15 ±
0.91 vs. post: 1.60 ± 0.42 mg·L
-1; p = 0.13) were lowered
in a clinically meaningful manner, although this decline
failed to reach statistical significance.
Dietary Data
As expected, several differences existed in dietary intake
from pre fast to the final week of the fast. These
included a decrease in total kilocalories (p = 0.0005),
protein grams (p = 0.0003), the percent of protein (p =
0.004), fat grams (p = 0.003), saturated fat (p < 0.0001),
trans fat (p = 0.006), and cholesterol (p < 0.0001). An
increase in the percent of carbohydrate intake (p =
0.0002), fiber (p < 0.0001), and vitamin C (p = 0.002)
was also noted. Data are presented in Table 5.
Discussion
Results from the present study indicate that a 21 day
Daniel Fast 1) significantly reduces systolic and diastolic
Table 1 Mental and physical health, hemodynamic, and
anthropometric data of men and women before and
after a 21 day Daniel Fast
Variable Pre Post
Mental Health 53.5.6 ± 0.9 51.7 ± 1.2
Physical Health 55.6 ± 0.6 55.6 ± 0.7
Heart Rate (bpm) 68.2 ± 1.7 64.5 ± 1.4
Systolic Blood Pressure (mmHg)* 114.7 ± 2.3 105.9 ± 2.1
Diastolic Blood Pressure (mmHg)** 72.2 ± 1.6 67.0 ± 1.4
Weight (kg) 77.5 ± 3.0 74.7 ± 2.7
BMI (kg·m
-2) 27.0 ± 0.9 26.0 ± 0.8
Waist (cm) 92.2 ± 2.0 90.4 ± 2.0
Hip (cm) 105.8 ± 1.8 104.5 ± 1.7
Waist:Hip 0.87 ± 0.01 0.87 ± 0.01
Total Body Fat (%) 30.2 ± 1.6 29.9 ± 1.6
Trunk Body Fat (%) 29.7 ± 1.7 29.1 ± 1.7
Fat Mass (kg) 24.2 ± 1.9 23.1 ± 1.8
Fat Free Mass (kg) 53.8 ± 2.0 52.1 ± 1.9
Values are mean ± SEM.
*p=0 . 0 0 7
** p = 0.03
No other statistically significant differences noted (p > 0.05).
Table 2 Complete blood count data of men and women
before and after a 21 day Daniel Fast
Variable Pre Post
WBC (10
3·μL
-1)* 5.7 ± 0.2 5.0 ± 0.2
RBC (10
6·μL
-1) 4.4 ± 0.1 4.4 ± 0.1
Hemoglobin (g·dL
-1) 13.7 ± 0.2 13.7 ± 0.2
Hematocrit (%) 39.7 ± 0.5 39.6 ± 0.5
MCV (fL) 89.3 ± 0.6 89.5 ± 0.6
MCH (pg) 30.9 ± 0.3 31.0 ± 0.3
MCHC (g·dL
-1) 34.6 ± 0.1 34.6 ± 0.1
RDW (%) 13.3 ± 0.2 13.2 ± 0.2
Platelets (10
3·μL
-1) 237.5 ± 8.9 222.5 ± 8.5
Neutrophils (%) 55.8 ± 1.4 54.1 ± 1.7
Lymphocytes (%) 33.9 ± 1.2 35.2 ± 1.5
Monocytes (%) 7.0 ± 0.3 7.7 ± 0.3
Eosinophils (%) 2.8 ± 0.3 2.4 ± 0.2
Basophils (%) 0.5 ± 0.1 0.6 ± 0.1
Values are mean ± SEM.
* p = 0.03
No other statistically significant differences noted (p > 0.05).
Table 3 Metabolic panel data of men and women before
and after a 21 day Daniel Fast
Variable Pre Post
Glucose (mg·dL
-1) 86.9 ± 1.5 84.8 ± 1.0
BUN (mg·dL
-1)* 13.1 ± 0.6 10.1 ± 0.6
Creatinine (mg·dL
-1) 0.9 ± 0.0 0.9 ± 0.0
BUN:Creatinine** 14.7 ± 0.6 11.7 ± 0.7
Sodium (mmol·L
-1) 138.7 ± 0.3 139.1 ± 0.3
Potassium (mmol·L
-1) 4.3 ± 0.1 4.4 ± 0.1
Chloride (mmol·L
-1) 102.6 ± 0.3 102.6 ± 0.3
CO2 (mmol·L
-1) 25.3 ± 0.3 25.9 ± 0.3
Calcium (mg·dL
-1) 9.4 ± 0.1 9.5 ± 0.1
Protein (g·dL
-1)*** 7.0 ± 0.1 6.8 ± 0.1
Albumin (g·dL
-1) 4.3 ± 0.0 4.2 ± 0.0
Globulin (g·dL
-1) 2.7 ± 0.1 2.6 ± 0.1
A:G 1.6 ± 0.0 1.6 ± 0.0
Bilirubin (mg·dL
-1) 0.5 ± 0.0 0.6 ± 0.1
Alk Phos (IU·L
-1) 63.8 ± 3.3 64.7 ± 3.1
AST (SGOT) (IU·L
-1) 23.0 ± 1.6 21.4 ± 0.6
ALT (SGPT) (IU·L
-1) 19.7 ± 1.2 18.0 ± 0.9
Values are mean ± SEM.
* p = 0.003
** p = 0.005
*** p = 0.05
No other statistically significant differences noted (p > 0.05).
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HDL cholesterol, 3) reduces insulin, HOMA-IR, and C-
reactive protein in a clinically meaningful, although sta-
tistically insignificant manner, 4) does not cause any
negative effects on blood count or metabolic panel
values, 5) is well-tolerated, and 6) may be useful as a
nutrition education tool for men and women. To our
knowledge, this is the first scientific investigation of the
Daniel Fast. Subsequent statistical analyses indicated no
interactions between normal weight and overweight/
obese subjects, men and women, and exercise trained
and untrained subjects (as discussed below). This sug-
gests that a wide variety of individuals may benefit from
a dietary approach in accordance with the Daniel Fast.
As we were not concerned with weight status, sex, or
training status comparisons in this initial study, coupled
with the fact that no interactions were noted for any of
the above-mentioned comparisons, only pooled data are
presented in the tables and discussed within this
manuscript.
It is important to note that our findings are in refer-
ence to relatively healthy, young to middle age men and
women (age range: 20-62 years), with a wide BMI range
(18.0 kg·m
-2 to 40.6 kg·m
-2), and varied regular exercise
and dietary habits. Interestingly, we noted similar find-
ings in all subject groups (as discussed below). For
example, similar percent changes in all measured vari-
ables from pre to post fast were observed in subjects
who are of normal weight and low body fat (e.g., < 10%
for men and < 20% for women), who exercise regularly
f o r4 +h o u r sp e rw e e ka n de a tav e r y“clean” diet on a
regular basis (including vegetarians), as compared to
overweight/obese, sedentary subjects who consume a
relatively poor diet. However, it should be noted that
while the percent change in outcome measures was
similar between such individuals, the absolute values
were better for the normal weight, exercise enthusiasts
compared to the overweight/obese, sedentary subjects
(discussed below). Based on our collective findings, it is
possible that individuals with diagnosed metabolic and
cardiovascular disorders may experience clinically mean-
ingful results on such a dietary regimen. Future work
should consider the inclusion of such patients, as this
d i e tm a yb ec o n s i d e r e da na nti-inflammatory, anti-
atherogenic, anti-hypertensive, non-pharmacologic
approach to disease risk management.
W h i l ew ed i dn o t ear e d u c t i o no fb l o o dp r e s s u r e ,a s
well as a decrease in total (19%) and LDL cholesterol
(23%) with the Daniel Fast in just three weeks, findings
similar to those noted for other plant-based diets
[19-21], we also noted a decrease in HDL-C (14%).
While the total:HDL-C was improved slightly (Table 4),
the drop in HDL-C remains a concern. If this eating
plan is to be viewed as “heart healthy” in all aspects,
future studies involving the Daniel Fast may include
specific food choices (e.g., almonds, plantago ovata
husks, walnuts) [22-24] and/or dietary supplements
[25,26] noted to increase HDL-C, in an effort to main-
tain HDL-C while decreasing both total and LDL-C.
Aside from HDL-C, although insulin (24%), HOMA-IR
(26%), and C-reactive protein (49%) decreased during
the 21 day fast, these decreases failed to reach statistical
significance. A post hoc power analysis indicated that a
total of 57 subjects would be needed to demonstrate sta-
tistical significance for insulin and HOMA-IR, while 65
subjects would be needed for C-reactive protein. Future
studies may include a larger sample size in order to
improve the chance of achieving statistical significance
for these variables. Of course, inclusion of individuals
Table 4 Lipid panel data of men and women before and
after a 21 day Daniel Fast
Variable Pre Post
Cholesterol (mg·dL
-1)* 171.1 ± 4.6 138.7 ± 4.4
Triglycerides (mg·dL
-1) 85.1 ± 4.8 75.3 ± 3.6
HDL-C (mg·dL
-1)** 55.6 ± 2.5 47.6 ± 2.2
VLDL-C (mg·dL
-1) 17.0 ± 1.0 15.0 ± 0.7
LDL-C (mg·dL
-1)*** 98.4 ± 3.9 76.1 ± 3.5
Total:HDL-C 3.3 ± 0.1 3.1 ± 0.1
Values are mean ± SEM.
* p < 0.0001
** p = 0.02
*** p = 0.0004
No other statistically significant differences noted (p > 0.05).
Table 5 Dietary data of men and women before and
during the final seven days of a 21 day Daniel Fast
Variable Pre During P value
Kilocalories 2185 ± 94 1722 ± 85 0.0005
Protein (g) 92 ± 6 62 ± 5 0.0003
Protein (%) 17 ± 0 13 ± 0 0.004
Carbohydrate (g) 287 ± 14 269 ± 17 0.41
Carbohydrate (%) 53 ± 0 62 ± 0 0.0002
Fiber (g) 26 ± 2 40 ± 3 < 0.0001
Sugar (g) 95 ± 7 86 ± 6 0.37
Fat (g) 74 ± 5 54 ± 4 0.003
Fat (%) 30 ± 0 27 ± 0 0.20
Saturated Fat (g) 24 ± 2 9 ± 1 < 0.0001
Monounsaturated Fat (g) 14 ± 2 14 ± 2 0.89
Polyunsaturated Fat (g) 8 ± 1 9 ± 1 0.47
Trans Fat (g) 1 ± 0 0 ± 0 0.006
Omega 3 (mg) 711 ± 163 798 ± 202 0.77
Omega 6 (mg) 2510 ± 327 3341 ± 345 0.10
Cholesterol (mg) 225 ± 19 28 ± 20 < 0.0001
Vitamin C (mg) 70 ± 9 119 ± 12 0.002
Vitamin E (mg) 8 ± 2 11 ± 1 0.36
Vitamin A (RE) 404 ± 60 435 ± 70 0.70
Values are mean ± SEM.
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improve the chance of noting statistically significant
findings.
It is interesting to note that even those subjects who
were vegetarian prior to starting the fast experienced
dramatic reductions in total and LDL-C, in addition to
improvements in other markers. Clearly, the exclusion
of meat from the diet (as is the case for vegetarians) is
not the only dietary factor involved in raising circulating
cholesterol and other risk factors for cardiovascular and
metabolic disease. It is possible that multiple dietary fac-
tors, inclusive moderate and high fat dairy products, as
well as processed and packaged foods containing trans
fats, simple carbohydrates, and various additives and
preservatives can negatively affect the variables included
in the present design. Future study is needed to investi-
gate this effect.
Aside from the previously discussed variables, signifi-
cant effects were noted for white blood cells (Table 2),
blood urea nitrogen, blood urea nitrogen:creatinine, and
protein (Table 3). While the latter findings are likely
related to the lower protein intake (particularly meat)
observed in this study [27,28], the slight decrease in
white blood cells is not well-supported. It has been sug-
gested that ingestion of food additives and preservatives
can increase white blood cell count by triggering an
immune response due to a sensing of invading patho-
gens from the food stuff; however, we are unaware of
any scientific reports that confirm this hypothesis. In
the present plan, subjects’ diets were devoid of such
additives and preservatives, which may help to explain
the finding of lowered white blood cells. Moreover, any
reduction in saturated fat intake, as well as in body
weight or body fat levels, may have contributed to these
findings, as excess fat ingestion and increased adiposity
has been associated with increased inflammation.
Finally, in relation to our measured variables, although
we noted some positive changes in body weight and
other anthropometric variables from pre to post fast, no
change was of statistical significance (Table 1). This
indicates that the noted changes of significance in terms
of the bloodborne variables were not dependent on sim-
ple changes in body weight/fat. While both the type and
quality of food was indeed different while on the fast
compared to pre fast, the total kilocalorie intake of sub-
jects was also reduced approximately 20% (Table 5),
despite the freedom of ad libitum intake. This finding
indicates that the intake of natural, high fiber, low glyce-
mic carbohydrate foods enhances satiety and conse-
quently reduces kilocalorie intake [12,29]. Subjects did
not purposely restrict food intake, as evidenced by their
c o m m e n t s ,c o m p l i a n c et ot h ef a s t ,a n ds e l f - r e p o r t e d
satiety ratings. It is likely that subjects consumed a simi-
lar or greater volume of food as compared to pre fast,
despite consuming fewer total kilocalories; this is plausi-
ble, because the foods that were consumed during the
fast were more nutrient dense and less energy dense
compared to the foods consumed before the fast. This
includes the increased intake of fruit during the fast,
which resulted in a similar amount of sugar to be con-
sumed as compared to pre fast, although seemed to pro-
vide increased satiety, likely due to the fiber content of
some fruits. Despite this, from a pure weight loss point
of view, it is likely that a longer fast duration (> 21
days) would be necessary to observe statistically signifi-
cant and clinically meaningful changes in anthropo-
metric variables in our subjects. As mentioned earlier,
many of our subjects were already in very good physical
condition prior to starting the fast, and therefore had lit-
tle room for improvement. Inclusion of a homogeneous
sample of obese subjects would likely yield statistically
significant findings for many of the anthropometric
variables.
Besides the anthropometric variables, we noted no
changes of statistical significance with regards to the
blood count (Table 2), metabolic panel (Table 3), or
lipid panel (Table 4) variables not previously discussed.
In fact, most variables were nearly identical from pre to
post fast. Based on these findings, the short-term effects
of the Daniel Fast do not pose any health concerns.
Future studies including longer fasting protocols should
continue to monitor clinical parameters in order to
extend the present findings.
Although our intention with this study was not to
make comparisons between normal weight and over-
weight/obese subjects, in an attempt to clarify our find-
ings we also analyzed data using a 2 (weight status:
normal weight vs. overweight/obese) × 2 (pre/post fast)
analysis of variance. No interaction effects were noted
for any variable (p > 0.05), indicating that normal weight
and overweight/obese subjects respond to the Daniel
Fast in a similar manner. However, aside from having
higher body weight, BMI, total and trunk percent body
fat and fat mass, and waist:hip (p < 0.0001), overweight/
obese subjects were noted as having higher heart rate
(p = 0.01), systolic blood pressure (p = 0.0001), diastolic
blood pressure (p = 0.005), glucose (p = 0.007), insulin
(p < 0.0001), HOMA-IR (p = 0.002), total cholesterol
(p = 0.003), triglycerides (p = 0.02), VLDL-C = 0.03),
LDL-C (p < 0.0001), and total:HDL-C (p < 0.0001) as
compared to normal weight subjects. Each of these
differences was expected based on prior literature.
We also analyzed data using a 2 (sex) × 2 (pre/post
fast) analysis of variance. No interaction effects were
noted for any variable (p > 0.05), indicating that men
and women respond to the Daniel Fast in a similar
manner. Men were noted as having higher body weight
(p < 0.0001), fat free mass (p < 0.0001), waist:hip
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stolic blood pressure(p < 0.0001), glucose (p < 0.0001),
insulin (p = 0.008), HOMA-IR (p = 0.002), blood urea
nitrogen (p = 0.006), and total:HDL-C (p = 0.04) as
compared to women. Women were noted as having
higher total percent body fat (p < 0.0001), total choles-
terol (p = 0.02), and HDL-C (p = 0.0007) compared to
men.
Finally, for completeness of analysis, we analyzed data
using a 2 (training status: trained vs. untrained) × 2
(pre/post fast) analysis of variance. No interaction effects
were noted for any variable (p > 0.05), indicating that
exercise trained and untrained men and women respond
to the Daniel Fast in a similar manner. Untrained sub-
jects were noted as having higher BMI (p = 0.04), total
(p = 0.0003) and trunk (p = 0.002) percent body fat, and
fat mass (p = 0.02), as well as total cholesterol (p =
0.006) and LDL-C (p = 0.05) as compared to trained
subjects. Trained subjects had higher fat free mass (p =
0.03) as compared to untrained subjects.
While it is obvious that the change in subjects’ dietary
intake is responsible for our findings, difficulty lies in
determining which specific dietary component is most
important in this regard. Because we have included mul-
tiple outcome measures in this initial study, in addition
to the measurement of multiple dietary variables, a com-
plete analysis of predictor and response variables would
be the topic of another manuscript. It is likely that the
combination of decreased kilocalorie, saturated fat, and
cholesterol intake, coupled with an increase in nutrient
and fiber-rich fruit, vegetable, and whole grain intake,
contributed to our findings. Moreover, it is possible that
the elimination of food additives, preservatives, and pro-
cessing agents, in addition to the decrease in protein
intake (methionine included), could be partly responsi-
ble for our findings. Future study is needed, ideally
inclusive of a larger sample of subjects, to provide more
definitive answers to the above hypotheses.
Conclusion
Our data indicate that exercise trained and untrained
individuals, inclusive of normal weight, overweight, and
obese men and women can benefit from a dietary
approach in accordance with the Daniel Fast. This is
evidenced by reductions in total and LDL cholesterol,
systolic and diastolic blood pressure, and trends for
reductions in insulin, HOMA-IR, and C-reactive protein.
The diet plan was well-tolerated by subjects, with sev-
eral noting a desire to continue with the plan long-term,
and appears to provide a default nutrition education.
Follow-up studies should include randomized designs,
possibly inclusive of small daily allotments of dairy and
lean meat/fish in order to boost compliance and to
minimize long-term nutrient deficiencies. Such studies
would seek to determine the feasibility of both a stan-
dard and slightly modified Daniel Fast for long-term
i n t a k e ,a sw e l la sm o d i f i c a t ions of this approach for
maintenance within a lifestyle eating plan aimed at opti-
mal health, inclusive of food choices and/or nutritional
supplements aimed at maintaining HDL-C. In particular,
such studies may include patients with diagnosed meta-
bolic (e.g., pre-diabetes and diabetes) and cardiovascular
disorders (e.g., hypertension and hypercholesterolemia),
as such individuals may experience clinically relevant
results manifesting in improved disease prognosis.
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